1. Reduced expression of HSP27 following HAD-B treatment is associated with Her2 downregulation in NIH:OVCAR-3 human ovarian cancer cells
- Author
-
Kyung-Hee Kim, Min Kyung Kim, Kyun Heo, Nitin Ambade, Byong Chul Yoo, Kuo Chu Li, and Hwa-Seung Yoo
- Subjects
Cancer Research ,Proteome ,Receptor, ErbB-2 ,HSP27 Heat-Shock Proteins ,Down-Regulation ,Apoptosis ,Biochemistry ,Downregulation and upregulation ,Hsp27 ,Cell Line, Tumor ,Genetics ,Humans ,Neoplasm Invasiveness ,Phosphorylation ,Molecular Biology ,Protein kinase B ,Heat-Shock Proteins ,PI3K/AKT/mTOR pathway ,Cell Proliferation ,Ovarian Neoplasms ,biology ,Oncogene ,Cell growth ,Ovary ,Cell cycle ,Antineoplastic Agents, Phytogenic ,Medicine, Korean Traditional ,Oncology ,Cancer research ,biology.protein ,Molecular Medicine ,Female ,Signal transduction ,Molecular Chaperones - Abstract
The Korean traditional medicine, HangAmDan (HAD), was developed in 1996 for use as an antitumor agent, and has since been modified to HAD‑B (an altered form of HAD), in order to potentiate its therapeutic effects. In the present study, the effect of HAD‑B on the proliferation and invasion of NIH:OVCAR‑3 and SKOV‑3 human ovarian cancer cell lines was investigated. In addition, the expression of major signal transduction molecules and changes in the proteome in these cells were measured. HAD‑B treatment effectively induced a reduction in the levels of cell proliferation in serum‑free conditioned media. However, unaltered levels of PARP and caspase‑3 indicated that HAD‑B does not reduce proliferation by inducing apoptotic cell death. Fluorescence‑activated cell sorting analysis revealed no significant change in apoptosis following HAD-B treatment. Invasion assay results indicated a reduced rate of invasion following HAD‑B treatment. HAD‑B also influenced the expression of major signal transduction molecules; the phosphorylation of mTOR and AKT was reduced, while that of ERK was increased. Alterations in the proteomes of the two cell lines were investigated following HAD‑B treatment. Among the 9 proteins with differential expression, heat‑shock protein β‑1 (HSP27) was downregulated in NIH:OVCAR‑3 cells treated with HAD‑B. The reduced expression of HSP27 was associated with human epidermal growth factor receptor 2 (Her2) downregulation in these cells. In conclusion, the results of the current proteome assessment suggest that HAD‑B has the potential to suppress the proliferation and invasion of human ovarian cancer cells. HAD‑B treatment of NIH:OVCAR‑3 cells suppressed HSP27 expression and was also associated with Her2 downregulation.
- Published
- 2015